NICE guidance on obesity management emphasises the importance of regular clinical review for patients receiving weight management medications, with follow-up appointments typically scheduled at 3-month intervals to discuss effectiveness and any side effects
Proper reconstitution of the lyophilized peptide with bacteriostatic water is the first critical step
Advances in Gerontology, 11 , 53-58
It was approved in the UK in 2023 for weight management in adults with: BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related condition The medication works through several mechanisms: Reduces hunger signals by acting on the brains appetite control centre Slows stomach emptying , creating longer-lasting fullness after meals Reduces food cravings , particularly for ultra-processed foods Improves blood sugar control by enhancing insulin function Clinical trials show that people taking Wegovy lose an average of 15% of their body weight after 68 weeks, compared to 2.4% with placebo
Corticosteroids for preventing postherpetic neuralgia
This effect is dose-dependent, with appetite suppression often increasing during dose titration (usually starting at 0.25mg weekly, then increasing to 0.5mg or 1mg)